Related Experiment Video
Updated: May 25, 2026

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
Hypothermia therapy: neurological and cardiac benefits
Cédric Delhaye1, Michael Mahmoudi, Ron Waksman
1Department of Internal Medicine, Division of Cardiology, Washington Hospital Center, 110 Irving Street, Washington, DC 20010, USA.
Insights
Hypothermia therapy (HT) improves outcomes for cardiac arrest patients but lacks clear benefits for acute myocardial infarction. Guidelines recommend HT for specific cardiac arrest survivors, with ongoing research for broader applications.
Area of Science:
- Cardiology
- Neurology
- Critical Care Medicine
Background:
- Hypothermia therapy (HT) offers neuroprotective and cardioprotective effects.
- Its efficacy is well-established in cardiac arrest (CA) patients with coma.
- Evidence for HT in acute myocardial infarction (MI) is still developing.
Purpose of the Study:
- To review the clinical evidence for hypothermia therapy in post-cardiac arrest and acute myocardial infarction.
- To discuss the mechanisms of action, cooling techniques, and adverse effects of HT.
Main Methods:
- Review of randomized controlled trials and observational studies on hypothermia therapy.
- Analysis of clinical guidelines and expert recommendations.
- Examination of physiological mechanisms and adverse event profiles.
Main Results:
- Randomized studies confirm HT reduces mortality and improves neurological outcomes in cardiac arrest patients, leading to guideline recommendations.
- Observational studies support the feasibility and early application of HT in various CA scenarios, including non-ventricular fibrillation CA and post-resuscitation shock.
- Current clinical evidence does not support HT as a standard of care for acute myocardial infarction due to insufficient demonstrated net benefit.
Conclusions:
- Hypothermia therapy is a recommended intervention for unconscious adult patients with spontaneous circulation after out-of-hospital cardiac arrest due to ventricular fibrillation.
- Further research is needed to establish the role and net benefit of HT in patients with acute myocardial infarction.
- Understanding HT's mechanisms, techniques, and adverse effects is crucial for its safe and effective clinical application.
Abstract:
Due to its protective effect on the brain and the myocardium, hypothermia therapy (HT) has been extensively studied in cardiac arrest patients with coma as well as in patients presenting with acute myocardial infarction (MI). In the setting of cardiac arrest, randomized studies have shown that HT decreases mortality and improves neurological outcomes. Subsequent guidelines have therefore recommended cooling (32°C to 34°C) for 12 to 24 h in unconscious adult patients with spontaneous circulation after out-of-hospital cardiac arrest due to ventricular fibrillation. Observational studies have also confirmed the feasibility of this therapy in clinical practice and support its early application in patients with nonventricular fibrillation cardiac arrest and in post-resuscitation circulatory shock. In patients with acute MI, available clinical evidence does not yet support HT as the standard of care, because no study to date has shown a clear net benefit in such a cohort. After a brief review of the mechanisms of action for HT, we provide a review of the clinical evidence, cooling techniques, and potential adverse effects associated with HT in the setting of post-cardiac arrest patient and acute MI.
More Related Videos
Related Concept Videos
Decreased Body Temperature
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Increased Body Temperature
Cardiopulmonary Resuscitation IV: Pharmacological Management
Thermoregulation
Homeostatic Imbalances in Body Temperature

